与艾滋病毒相关的外腔内原发泄淋巴瘤呈现为支气管质量:病例报告
Francisco Novela1, Bruno Silva2,3, João Matos1
1Department of Infectious Diseases, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
International journal of STD & AIDS
|July 30, 2025
概括
这项案例研究突出显示了一例罕见的与人类疹病毒-8 (HHV8) 相关的淋巴瘤,该淋巴瘤发生在患有支气管质量的HIV阳性患者身上. 早期诊断和化疗治疗导致了有效的反应.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 初级溢出淋巴瘤 (PEL) 是一种与人类疹病毒-8 (HHV-8) 感染密切相关的侵袭性非霍奇金淋巴瘤.
- PEL通常影响患有高级人类免疫缺陷病毒 (HIV) 感染和获得性免疫缺陷综合征 (AIDS) 的个人.
- 洞外PEL,呈现在体外空洞,是非常罕见的,带来诊断挑战.
研究的目的:
- 在艾滋病毒阳性患者中报告与HHV-8相关的异常外腔PEL病例.
- 强调在免疫功能低下个体的支气管群体的差异诊断中考虑PEL的重要性.
- 为了说明诊断途径和治疗反应在这样一个罕见的呈现.
主要方法:
- 一个52岁的男性的临床表现,持续咳,发烧,夜间出汗和体重减轻.
- 诊断工作包括艾滋病毒检测 (CD4计数:42/mm3),排除机会性感染和支气管镜检查.
- 活检的支气管质量的组织病理学和免疫组织化学分析证实了外腔内PEL和HHV-8的关联.
主要成果:
- 这名患者被诊断出患有与人类疹病毒-8 (HHV-8) 相关的外腔体初级输液淋巴瘤 (PEL).
- 支气管质量通过活检,组织学和免疫组织化学证实.
- 开始抗逆转录病毒疗法和CHOP化疗导致了有效的临床反应.
结论:
- 与HHV-8相关的洞外PEL可以在HIV感染个体中异常呈现为支气管质量.
- 这一案例强调了需要将PEL纳入艾滋病毒/艾滋病患者的淋巴增殖障碍和无法解释的呼吸道症状或质量的差异诊断中的必要性.
- 及时诊断和与化疗结合的抗逆转录病毒疗法对于管理这种罕见的瘤疾病至关重要.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
06:03Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules
Published on: May 23, 2015
22.5K
相关概念视频
Pleural Effusion I: Introduction
1.8K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.8K
Pulmonary Tuberculosis III
446
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
446
Pulmonary Tuberculosis II
362
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
362
Pulmonary Tuberculosis I
326
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
326
Pulmonary Tuberculosis V
239
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
239
Pulmonary Tuberculosis IV
206
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
206
